News
Christophe Hamal to become CEO of Baloise in Belgium
Christophe Hamal to become CEO of Baloise in Belgium
HBM Healthcare Investments Half-Year Report September 2022
HBM Healthcare Investments Half-Year Report September 2022
Evolva receives grant from US CDC in the amount of USD 540,000
Evolva receives grant from US CDC in the amount of USD 540,000
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-Adhoc: BB Biotech AG publishes its interim report
EQS-News: BB BIOTECH AG: US drug pricing legislation drives biotech business to adapt for further innovation
EQS-News: BB BIOTECH AG: US drug pricing legislation drives biotech business to adapt for further innovation
Gurit reports net sales of CHF 362.8 million in the first nine months of 2022
Gurit reports net sales of CHF 362.8 million in the first nine months of 2022
mobilezone holding ag completes first tranche of CHF 12 million share buyback programme for the purpose of capital reduction
mobilezone holding ag completes first tranche of CHF 12 million share buyback programme for the purpose of capital reduction
Rieter Investor Update 2022 Ad-hoc announcement pursuant to Art. 53 LR
Rieter Investor Update 2022
Ad-hoc announcement pursuant to Art. 53 LR
Bystronic AG: Bystronic launches a new machine-level protection service with NanoLock Security
Bystronic AG: Bystronic launches a new machine-level protection service with NanoLock Security
Hudson Honored With 2022 All In For Students Philanthropic Partner Award From Communities In Schools
Hudson Honored With 2022 All In For Students Philanthropic Partner
Award From Communities In Schools
Approval of extension of exemptions from SIX disclosure and publicity obligations
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma AG (Vifor) announced today that by decision dated October 19, 2022, SIX Exchange Regulation AG (SER) has approved an
ABB: Q3 2022 Results
ABB (SWX:ABBN):
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221019006028/en/
KEY FIGURES
With accelerated Growth and despite ongoing Bottlenecks Well on Track for Full Year 2022
With accelerated Growth and despite ongoing Bottlenecks Well on Track for Full Year 2022
Initial recovery in revenue and profitability, order intake under pressure
Initial recovery in revenue and profitability, order intake under pressure
Comet achieves an excellent sales performance in Q3
Comet achieves an excellent sales performance in Q3
Kuros Biosciences awarded 2022 Spine Technology Award for MagnetOs Flex Matrix by Orthopedics This Week
Kuros Biosciences awarded 2022 Spine Technology Award for MagnetOs Flex Matrix by Orthopedics This Week
Hudson Extends Term At Charleston International Airport With A New, Ten-Year Contract
Hudson Extends Term At Charleston International Airport With A New, Ten-Year Contract
Jungfraubahn Holding AG: Matthias Bütler, Executive Board member and Head of Market-ing, to leave the company at the end of April 2023
Jungfraubahn Holding AG: Matthias Bütler, Executive Board member and Head of Market-ing, to leave the company at the end of April 2023
Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer
Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer
Bystronic AG: Accelerated sales growth in the third quarter of 2022
Bystronic AG: Accelerated sales growth in the third quarter of 2022
DKSH Strengthens its Healthcare Own Brands Business With the Acquisition of two Ear Care Brands
DKSH Strengthens its Healthcare Own Brands Business With the Acquisition of two Ear Care Brands